Clinical trial
Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian…
NCT00417144 · Eugonia, Other · Unknown status
Key facts
| NCT number | NCT00417144 |
|---|---|
| Title | Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients |
| Official title | Randomized Controlled Trial Comparing the Effect of GnRH Agonist and Antagonist Ovarian Stimulation Protocols in PCOS Patients |
| Lead sponsor | Eugonia, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome |
| Intervention type | Drug |
| Interventions | Arvekap 0.1mg (Triptorelin, Ipsen, France), Ganirelix 0.25mg (Orgalutran, Organon, The Netherlands) |
| Enrollment | 200 |
| Start date | Nov 1, 2003 |
| Completion | May 1, 2007 |
| First posted | Dec 29, 2006 |
| Last update posted | Dec 29, 2006 |
| Countries | Greece |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: